Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new resource aimed to support psychiatrists dealing with the death of a patient by suicide is now available from the Centre for Suicide Research at the University of Oxford.

Woman explaining something serious to another woman listening.

Director of the Centre for Suicide Research, University of Oxford, and Consultant Psychiatrist, Oxford Health NHS Foundation Trust, Professor Keith Hawton, said,

"The sad loss of patients to suicide can understandably have severe emotional and psychological effects on staff. A group of senior clinicians (psychiatrists, nurses and clinical psychologists), most of whom work in Oxford Health NHS Foundation Trust, formed a working party associated with the Centre for Suicide Research to investigate the impact on clinical staff of loss of patients to suicide. We have produced this new resource for psychiatrists who experience the death of a patient by suicide. The resource is partly based on findings of a survey of doctors about their experiences, which was carried out because of concerns about the considerable impacts loss of patients to suicide can have on psychiatrists.  We are in the process of also developing a resource for other mental health staff, again based on findings of a survey of experiences."

If a patient dies by suicide: A Resource for Psychiatrists, has been produced to support psychiatrists at all stages of their career, from trainees to experienced consultants. Its purpose is to provide information about a difficult topic that psychiatrists often avoid discussing, to reduce a sense of isolation, and to recommend helpful resources for those psychiatrists who have this experience.

The guide was developed following a survey of psychiatrists who had experienced the death of a patient by suicide (Gibbons et al. 2019), from a review of the limited research literature in this area and from personal experiences. 

 

We hope that this booklet will prove helpful for psychiatrists in the aftermath of patient suicide and for those who haven’t faced such a loss, including trainees, to help them cope should this happen in future.
Professor Keith Hawton.

 

 

 

 

 

 

 

 

 

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Risk of Death Doubled in Patients with Chronic Disease and Co-occurring Psychiatric Disorders

A new study led by Professor Seena Fazel at the University of Oxford found that among patients with chronic, non-communicable diseases, the risk of death is more than doubled if they also have a psychiatric disease.

Ethics in Mental Health Digital Innovations for Young People in Africa: Digital Campaign

This campaign was led by a team of 29 Early Career Researchers (ECRs) and a Young People's Advisory Group (YPAG) across five African countries. The young people wanted to share contextual and accessible information on digital mental health and ethical issues that are important to them.

How Mindfulness May Improve Body Satisfaction and Mood

New research from Emma Osborne, Research Assistant at the Centre for Research on Eating Disorders (CREDO) at the University of Oxford (and PhD Candidate at the University of Bath), and Dr Melissa Atkinson, University of Bath, investigated two ways in which mindfulness might improve body satisfaction and mood.

Review Highlights Risk Factors Associated with Violence in Schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients

C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.

A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.